Laboratory evaluation of the effectiveness of pathogen reduction procedures for bacteria

Transfusion Medicine and Hemotherapy

Volumn 38, Issue 4, 2011, Pages 242-250

  Müller, Thomas H ^a   Montag, Thomas ^b   Seltsam, Axel W ^a  

^a DRK Blutspendedienst NSTOB   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Bacteria, pathogen reduction; Cellular blood component; Platelet concentrate; Sterility

Indexed keywords

THROMBOCYTE CONCENTRATE;

ANTIVIRAL ACTIVITY; ARTICLE; BACTERIUM CONTAMINATION; BLOOD COMPONENT; CONTROLLED STUDY; LABORATORY; NONHUMAN; PATHOGEN CLEARANCE; PROTEIN POLYMORPHISM;

EID: 80052215703     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000330338     Document Type: Article

References (58)

1. Goldman M, Roy G, Frechette N, Decary F, Massicotte L, Delage G: Evaluation of donor skin disinfection methods. Transfusion 1997;37:309-312. (Pubitemid 27142860)
2. Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS, Goodman JL: Bacterial contamination of blood components: risks, strategies, and regulation: Joint ASH and AABB educational session in transfusion medicine. Hematology Am Soc Hematol Educ Program 2003:575-589.
3. Blajchman MA, Goldman M, Baeza F: Improving the bacteriological safety of platelet transfusions. Transfus Med Rev 2004;18:11-24. (Pubitemid 38018800)
4. Ramirez-Arcos S, Goldman M: Skin disinfection methods: prospective evaluation and postimplementation results. Transfusion 2010;50:59-64.
5. Benjamin RJ, Dy B, Warren R, Lischka M, Eder AF: Skin disinfection with a single-step 2% chlorhexidine swab is more effective than a two-step povidone-iodine method in preventing bacterial contamination of apheresis platelets. Transfusion 2011;51:531-538.
6. McDonald CP: Bacterial risk reduction by improved donor arm disinfection, diversion and bacterial screening. Transfus Med 2006;16:381-396. (Pubitemid 44813848)
7. de Korte D, Curvers J, de Kort WL, Hoekstra T, van der Poel CL, Beckers EA, Marcelis JH: Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 2006;46:476-485. (Pubitemid 43334104)
8. Satake M, Mitani T, Oikawa S, Nagumo H, Sugiura S, Tateyama H, Awakihara S, Mitsutomi Y, Muraoka M, Tadokoro K: Frequency of bacterial contamination of platelet concentrates before and after introduction of diversion method in Japan. Transfusion 2009;49:2152-2157.
9. McDonald CP, Rogers A, Cox M, Smith R, Roy A, Robbins S, Hartley S, Barbara JA, Rothenberg S, Stutzman L, Widders G: Evaluation of the 3d BacT/ALERT automated culture system for the detection of microbial contamination of platelet concentrates. Transfus Med 2002;12:303-309. (Pubitemid 35178099)
10. Ribault S, Harper K, Grave L, Lafontaine C, Nannini P, Raimondo A, Faure IB: Rapid screening method for detection of bacteria in platelet concentrates. J Clin Microbiol 2004;42:1903-1908. (Pubitemid 38637800)
11. Castro E, Bueno JL, Barea L, Gonzalez R: Feasibility of implementing an automated culture system for bacteria screening in platelets in the blood bank routine. Transfus Med 2005;15:185-195. (Pubitemid 40827472)
12. McDonald CP, Pearce S, Wilkins K, Colvin J, Robbins S, Colley L, Taylor J, Barbara JA: Pall EBDS: An enhanced bacterial detection system for screening platelet concentrates. Transfus Med 2005;15:259-268. (Pubitemid 41633114)
13. Schrezenmeier H, Walther-Wenke G, Müller TH, Weinauer F, Younis A, Holland-Letz T, Geis G, Asmus J, Bauerfeind U, Burkhart J, Deitenbeck R, Förstemann E, Gebauer W, Hochsmann B, Karakassopoulos A, Liebscher UM, Sanger W, Schmidt M, Schunter F, Sireis W, Seifried E: Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 2007;47:644-652. (Pubitemid 46449625)
14. Montag T: Strategies of bacteria screening in cellular blood components. Clin Chem Lab Med 2008;46:926-932.
15. Müller TH, Mohr H, Montag T: Methods for the detection of bacterial contamination in blood products. Clin Chem Lab Med 2008;46:933-946.
16. Murphy WG, Foley M, Doherty C, Tierney G, Kinsella A, Salami A, Cadden E, Coakley P: Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008;95:13-19. (Pubitemid 351799415)
17. Pearce S, Rowe GP, Field SP: Screening of platelets for bacterial contamination at the Welsh blood service. Transfus Med 2011;21:25-32.
18. Stainsby D, Williamson L, Jones H, Cohen H: 6 years of shot reporting-its influence on UK blood safety. Transfus Apher Sci 2004;31:123-131. (Pubitemid 40292137)
19. Dodd RY: Bacterial contamination and transfusion safety: experience in the United States. Transfus Clin Biol 2003;10:6-9. (Pubitemid 36433027)
20. Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, Arduino MJ, Holt SC, Carson LA, Banerjee SN, Jarvis WR: Transfusiontransmitted bacterial infection in the United States, 1998. through 2000. Transfusion 2001;41:1493-1499.
21. Walther-Wenke G, Doerner R, Montag T, Greiss O, Hornei B, Knels R, Strobel J, Volkers P, Däubener W: Bacterial contamination of platelet concentrates prepared by different methods: results of standardized sterility testing in Germany. Vox Sang 2006;90:177-182.
22. Brecher ME, Hay SN: Bacterial contamination of blood components. Clin Microbiol Rev 2005;18: 195-204. (Pubitemid 40170668)
23. Allain JP, Bianco C, Blajchman MA, Brecher ME, Busch M, Leiby D, Lin L, Stramer S: Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Transfus Med Rev 2005;19: 110-126. (Pubitemid 40544291)
24. Klein HG, Anderson D, Bernardi MJ, Cable R, Carey W, Hoch JS, Robitaille N, Sivilotti ML, Smaill F: Pathogen inactivation: making decisions about new technologies. Report of a consensus conference. Transfusion 2007;47:2338-2347.
25. Klein HG, Glynn SA, Ness PM, Blajchman MA: Research opportunities for pathogen reduction/inactivation of blood components: summary of an NHLBI workshop. Transfusion 2009;49:1262-1268.
26. Webert KE, Cserti CM, Hannon J, Lin Y, Pavenski K, Pendergrast JM, Blajchman MA: Proceedings of a consensus conference: pathogen inactivationmaking decisions about new technologies. Transfus Med Rev 2008;22:1-34. (Pubitemid 350193270)
27. Pelletier JP, Transue S, Snyder EL: Pathogen inactivation techniques. Best Pract Res Clin Haematol 2006;19:205-242. (Pubitemid 43118872)
28. Seghatchian J, de Sousa G: Pathogen-reduction systems for blood components: the current position and future trends. Transfus Apher Sci 2006;35:189-196. (Pubitemid 44839272)
29. Solheim BG: Pathogen reduction of blood components. Transfus Apher Sci 2008;39:75-82.
30. Marschner S, Goodrich R: Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light. Transfus Med Hemother 2011;38:8-18
31. Irsch J, Lin L: Pathogen inactivation of platelet and plasma blood components for transfusion using the INTERCEPT Blood SystemTM. Transfus Med Hemother 2011;38:19-31.
32. Seltsam A, Müller TH: UVC irradiation for pathogen reduction of platelet concentrates and plasma. Transfus Med Hemother 2011;38:43-54.
33. Henschler R, Seifried E, Mufti N: Development of the S-303 pathogen inactivation technology for red blood cell concentrates. Transfus Med Hemother 2011:33-42.
34. Goodrich RP, Gilmour D, Hovenga N, Keil SD: A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns. Transfusion 2009;49:1205-1216.
35. Mohr H, Lambrecht B, Bayer A, Spengler HP, Nicol SB, Montag T, Müller TH: Sterility testing of platelet concentrates prepared from deliberately infected blood donations. Transfusion 2006;46:486-491. (Pubitemid 43334105)
36. Lin L, Londe H, Janda JM, Hanson CV, Corash L: Photochemical inactivation of pathogenic bacteria in human platelet concentrates. Blood 1994;83: 2698-2706. (Pubitemid 24135864)
37. Lin L, Cook DN, Wiesehahn GP, Alfonso R, Behrman B, Cimino GD, Corten L, Damonte PB, Dikeman R, Dupuis K, Fang YM, Hanson CV, Hearst JE, Lin CY, Londe HF, Metchette K, Nerio AT, Pu JT, Reames AA, Rheinschmidt M, Tessman J, Isaacs ST, Wollowitz S, Corash L: Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997;37:423-435. (Pubitemid 27193557)
38. Lin L, Dikeman R, Molini B, Lukehart SA, Lane R, Dupuis K, Metzel P, Corash L: Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion 2004;44:1496-1504. (Pubitemid 39318986)
39. Liu W, Cimino GD, Corash L, Lin L: The extent of amotosalen photodegradation during photochemical treatment of platelet components correlates with the level of pathogen inactivation. Transfusion 2011;51:52-61.
40. Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP: Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004; 44:877-885. (Pubitemid 38738418)
41. Goodrich RP, Edrich RA, Goodrich LL, Scott CA, Manica KJ, Hlavinka DJ, Hovenga NA, Hansen ET, Gampp D, Keil SD, Gilmour DI, Li J, Martin CB, Platz MS: Chapter 5: the antiviral and antibacterial properties of riboflavin and light: applications to blood safety and transfusion medicine; in Silva E, Edwards AM (eds): Flavins: Photochemistry and Photobiology, Vol. 6. London, The Royal Society of Chemistry, 2006, pp 83-113.
42. Goodrich RP, Edrich RA, Li J, Seghatchian J: The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 2006;35:5-17. (Pubitemid 44354317)
43. Mohr H, Gravemann U, Bayer A, Müller TH: Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light. Transfusion 2009;49:1956-1963.
44. Mohr H, Steil L, Gravemann U, Thiele T, Hammer E, Greinacher A, Müller TH, Völker U: A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion 2009;49:2612-2624.
45. Zavizion B, Serebryanik D, Chapman J, Alford B, Purmal A: Inactivation of Gram-negative and Gram-positive bacteria in red cell concentrates using Inactine PEN110 chemistry. Vox Sang 2004; 87:143-149. (Pubitemid 39469771)
46. Wagner SJ, Skripchenko A, Cincotta L, Thompson-Montgomery D, Awatefe H: Use of a flexible thiopyrylium photosensitizer and competitive inhibitor for pathogen reduction of viruses and bacteria with retention of red cell storage properties. Transfusion 2005;45:752-760. (Pubitemid 40656389)
47. Skripchenko A, Wagner SJ, Thompson-Montgomery D, Awatefe H: Thiazole orange, a DNAbinding photosensitizer with flexible structure, can inactivate pathogens in red blood cell suspensions while maintaining red cell storage properties. Transfusion 2006;46:213-219. (Pubitemid 43381756)
48. Brecher ME, Holland PV, Pineda AA, Tegtmeier GE, Yomtovian R: Growth of bacteria in inoculated platelets: Implications for bacteria detection and the extension of platelet storage. Transfusion 2000;40:1308-1312.
49. Goodrich RP, Custer B, Keil S, Busch M: Defining 'adequate' pathogen reduction performance for transfused blood components. Transfusion 2010;50: 1827-1837.
50. Mohr H, Bayer A, Gravemann U, Müller TH: Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates. Transfusion 2006;46:949-955. (Pubitemid 43800913)
51. Knutson F, Alfonso R, Dupuis K, Mayaudon V, Lin L, Corash L, Hogman CF: Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function. Vox Sang 2000;78: 209-216. (Pubitemid 30481251)
52. Nussbaumer W, Allersdorfer D, Grabmer C, Rheinschmidt M, Lin L, Schönitzer D, Lass-Florl C: Prevention of transfusion of platelet components contaminated with low levels of bacteria: A comparison of bacteria culture and pathogen inactivation methods. Transfusion 2007;47:1125-1133. (Pubitemid 46934306)
53. Dumont LJ, Kleinman S, Murphy JR, Lippincott R, Schuyler R, Houghton J, Metzel P: Screening of single-donor apheresis platelets for bacterial contamination: the passport study results. Transfusion 2010;50:589-599.
54. Perez P, Salmi LR, Follea G, Schmit JL, de Barbeyrac B, Sudre P, Salamon R: Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study. Transfusion 2001;41:862-872. (Pubitemid 32642757)
55. Love EM, Soldan K: The Serious Hazards of Transfusion Steering Group. SHOT Annual Report 2000-2001. London, The Serious Hazards of Transfusion Group, 2002.
56. Störmer M, Vollmer T, Kleesiek K, Dreier J: Spore-forming organisms in platelet concentrates: a challenge in transfusion bacterial safety. Transfus Med 2008;18:371-376.
57. Wagner SJ, Eder AF: A model to predict the improvement of automated blood culture bacterial detection by doubling platelet sample volume. Transfusion 2007;47:430-433.
58. Störmer M, Arroyo A, Brachert J, Carrero H, Devine D, Epstein JS, Gabriel C, Gelber C, Goodrich R, Hanschmann KM, Heath DG, Jacobs MR, Keil S, de Korte D, Lambrecht B, Lee CK, Marcelis J, Marschner S, McDonald C, McGuane S, McKee M, Müller TH, Muthivhi T, Petterson A, Radziwon P, Ramirez-Arcos S, Reesink HW, Rojo J, Rood I, Schmidt M, Schneider CK, Seifried E, Sicker U, Wendel S, Wood EM, Yomtovian RH, Montag T: Establishment of the First International Repository for Transfusion Relevant Bacterial Reference Strains. Vox Sang 2011, accepted for publication.